Joerg Alte
Corporate Officer/Principal at FIDEsprit AG
Joerg Alte active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FIDEsprit AG | Corporate Officer/Principal | 2007-08-31 | - |
Career history of Joerg Alte
Former positions of Joerg Alte
| Companies | Position | Start | End |
|---|---|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | President | 1998-10-31 | 2000-03-31 |
| PROTEO, INC. | Director/Board Member | 1999-12-31 | - |
Statistics
International
| United States | 2 |
| Germany | 2 |
| Switzerland | 2 |
Operational
| Director/Board Member | 1 |
| President | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Proteo, Inc.
 Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
| FIDEsprit AG |
- Stock Market
- Insiders
- Joerg Alte
- Experience
